drugset
Drugs / Allogeneic adult mesenchymal bone marrow stem cells
last change Nov 2018 re-read 3 minutes ago

Allogeneic adult mesenchymal bone marrow stem cells

Cell therapy

Developed for
ischemic stroke
Investigated by
Chandler Regional Medical Center at Chandler AZ · Mercy Gilbert Medical Center at AZ · Stemedica Cell Technologies, Inc. · UCI Medical Center · University of California, San Diego

Trials 1

today NCT01297413 · Ph 1/2
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01297413 Feb 2011 → Sep 2017 ischemic stroke Stemedica Cell Technologies, Inc. Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Allogeneic adult mesenchymal bone marrow stem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01297413 ↗
Modality Cell therapy “allogeneic adult mesenchymal bone marrow stem cells” NCT01297413 ↗
Route Intravenous “administered intravenously” NCT01297413 ↗